Incidence rates and contemporary trends in primary urethral cancer

Standard

Incidence rates and contemporary trends in primary urethral cancer. / Wenzel, Mike; Nocera, Luigi; Collà Ruvolo, Claudia; Würnschimmel, Christoph; Tian, Zhe; Shariat, Shahrokh F; Saad, Fred; Briganti, Alberto; Tilki, Derya; Mandel, Philipp; Becker, Andreas; Kluth, Luis A; Chun, Felix K H; Karakiewicz, Pierre I.

in: CANCER CAUSE CONTROL, Jahrgang 32, Nr. 6, 06.2021, S. 627-634.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Wenzel, M, Nocera, L, Collà Ruvolo, C, Würnschimmel, C, Tian, Z, Shariat, SF, Saad, F, Briganti, A, Tilki, D, Mandel, P, Becker, A, Kluth, LA, Chun, FKH & Karakiewicz, PI 2021, 'Incidence rates and contemporary trends in primary urethral cancer', CANCER CAUSE CONTROL, Jg. 32, Nr. 6, S. 627-634. https://doi.org/10.1007/s10552-021-01416-2

APA

Wenzel, M., Nocera, L., Collà Ruvolo, C., Würnschimmel, C., Tian, Z., Shariat, S. F., Saad, F., Briganti, A., Tilki, D., Mandel, P., Becker, A., Kluth, L. A., Chun, F. K. H., & Karakiewicz, P. I. (2021). Incidence rates and contemporary trends in primary urethral cancer. CANCER CAUSE CONTROL, 32(6), 627-634. https://doi.org/10.1007/s10552-021-01416-2

Vancouver

Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF et al. Incidence rates and contemporary trends in primary urethral cancer. CANCER CAUSE CONTROL. 2021 Jun;32(6):627-634. https://doi.org/10.1007/s10552-021-01416-2

Bibtex

@article{bc5c3fc20196433d8ed4619600b2b08c,
title = "Incidence rates and contemporary trends in primary urethral cancer",
abstract = "PURPOSE: We assessed contemporary incidence rates and trends of primary urethral cancer.METHODS: We identified urethral cancer patients within Surveillance, Epidemiology and End Results registry (SEER, 2004-2016). Age-standardized incidence rates per 1,000,000 (ASR) were calculated. Log linear regression analyses were used to compute average annual percent change (AAPC).RESULTS: From 2004 to 2016, 1907 patients with urethral cancer were diagnosed (ASR 1.69; AAPC: -0.98%, p = 0.3). ASR rates were higher in males than in females (2.70 vs. 0.55), respectively and did not change over the time (both p = 0.3). Highest incidence rates were recorded in respectively ≥75 (0.77), 55-74 (0.71) and ≤54 (0.19) years of age categories, in that order. African Americans exhibited highest incidence rate (3.33) followed by Caucasians (1.72), other race groups (1.57) and Hispanics (1.57), in that order. A significant decrease occurred over time in Hispanics, but not in other race groups. In African Americans, male and female sex-stratified incidence rates were higher than in any other race group. Urothelial histological subtype exhibited highest incidence rate (0.92), followed by squamous cell carcinoma (0.41), adenocarcinoma (0.29) and other histologies (0.20). In stage stratified analyses, T1N0M0 stage exhibited highest incidence rate. However, it decreased over time (-3.00%, p = 0.02) in favor of T1-4N1-2M0 stage (+ 2.11%, p = 0.02).CONCLUSION: Urethral cancer is rare. Its incidence rates are highest in males, elderly patients, African Americans and in urothelial histological subtype. Most urethral cancer cases are T1N0M0, but over time, the incidence of T1N0M0 decreased in favor of T1-4N1-2M0.",
keywords = "Adenocarcinoma/diagnosis, Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell/diagnosis, Female, Humans, Incidence, Male, Middle Aged, Neoplasm Grading, SEER Program/trends, Sex Factors, Urethral Neoplasms/diagnosis",
author = "Mike Wenzel and Luigi Nocera and {Coll{\`a} Ruvolo}, Claudia and Christoph W{\"u}rnschimmel and Zhe Tian and Shariat, {Shahrokh F} and Fred Saad and Alberto Briganti and Derya Tilki and Philipp Mandel and Andreas Becker and Kluth, {Luis A} and Chun, {Felix K H} and Karakiewicz, {Pierre I}",
year = "2021",
month = jun,
doi = "10.1007/s10552-021-01416-2",
language = "English",
volume = "32",
pages = "627--634",
journal = "CANCER CAUSE CONTROL",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "6",

}

RIS

TY - JOUR

T1 - Incidence rates and contemporary trends in primary urethral cancer

AU - Wenzel, Mike

AU - Nocera, Luigi

AU - Collà Ruvolo, Claudia

AU - Würnschimmel, Christoph

AU - Tian, Zhe

AU - Shariat, Shahrokh F

AU - Saad, Fred

AU - Briganti, Alberto

AU - Tilki, Derya

AU - Mandel, Philipp

AU - Becker, Andreas

AU - Kluth, Luis A

AU - Chun, Felix K H

AU - Karakiewicz, Pierre I

PY - 2021/6

Y1 - 2021/6

N2 - PURPOSE: We assessed contemporary incidence rates and trends of primary urethral cancer.METHODS: We identified urethral cancer patients within Surveillance, Epidemiology and End Results registry (SEER, 2004-2016). Age-standardized incidence rates per 1,000,000 (ASR) were calculated. Log linear regression analyses were used to compute average annual percent change (AAPC).RESULTS: From 2004 to 2016, 1907 patients with urethral cancer were diagnosed (ASR 1.69; AAPC: -0.98%, p = 0.3). ASR rates were higher in males than in females (2.70 vs. 0.55), respectively and did not change over the time (both p = 0.3). Highest incidence rates were recorded in respectively ≥75 (0.77), 55-74 (0.71) and ≤54 (0.19) years of age categories, in that order. African Americans exhibited highest incidence rate (3.33) followed by Caucasians (1.72), other race groups (1.57) and Hispanics (1.57), in that order. A significant decrease occurred over time in Hispanics, but not in other race groups. In African Americans, male and female sex-stratified incidence rates were higher than in any other race group. Urothelial histological subtype exhibited highest incidence rate (0.92), followed by squamous cell carcinoma (0.41), adenocarcinoma (0.29) and other histologies (0.20). In stage stratified analyses, T1N0M0 stage exhibited highest incidence rate. However, it decreased over time (-3.00%, p = 0.02) in favor of T1-4N1-2M0 stage (+ 2.11%, p = 0.02).CONCLUSION: Urethral cancer is rare. Its incidence rates are highest in males, elderly patients, African Americans and in urothelial histological subtype. Most urethral cancer cases are T1N0M0, but over time, the incidence of T1N0M0 decreased in favor of T1-4N1-2M0.

AB - PURPOSE: We assessed contemporary incidence rates and trends of primary urethral cancer.METHODS: We identified urethral cancer patients within Surveillance, Epidemiology and End Results registry (SEER, 2004-2016). Age-standardized incidence rates per 1,000,000 (ASR) were calculated. Log linear regression analyses were used to compute average annual percent change (AAPC).RESULTS: From 2004 to 2016, 1907 patients with urethral cancer were diagnosed (ASR 1.69; AAPC: -0.98%, p = 0.3). ASR rates were higher in males than in females (2.70 vs. 0.55), respectively and did not change over the time (both p = 0.3). Highest incidence rates were recorded in respectively ≥75 (0.77), 55-74 (0.71) and ≤54 (0.19) years of age categories, in that order. African Americans exhibited highest incidence rate (3.33) followed by Caucasians (1.72), other race groups (1.57) and Hispanics (1.57), in that order. A significant decrease occurred over time in Hispanics, but not in other race groups. In African Americans, male and female sex-stratified incidence rates were higher than in any other race group. Urothelial histological subtype exhibited highest incidence rate (0.92), followed by squamous cell carcinoma (0.41), adenocarcinoma (0.29) and other histologies (0.20). In stage stratified analyses, T1N0M0 stage exhibited highest incidence rate. However, it decreased over time (-3.00%, p = 0.02) in favor of T1-4N1-2M0 stage (+ 2.11%, p = 0.02).CONCLUSION: Urethral cancer is rare. Its incidence rates are highest in males, elderly patients, African Americans and in urothelial histological subtype. Most urethral cancer cases are T1N0M0, but over time, the incidence of T1N0M0 decreased in favor of T1-4N1-2M0.

KW - Adenocarcinoma/diagnosis

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Carcinoma, Squamous Cell/diagnosis

KW - Female

KW - Humans

KW - Incidence

KW - Male

KW - Middle Aged

KW - Neoplasm Grading

KW - SEER Program/trends

KW - Sex Factors

KW - Urethral Neoplasms/diagnosis

U2 - 10.1007/s10552-021-01416-2

DO - 10.1007/s10552-021-01416-2

M3 - SCORING: Journal article

C2 - 33751293

VL - 32

SP - 627

EP - 634

JO - CANCER CAUSE CONTROL

JF - CANCER CAUSE CONTROL

SN - 0957-5243

IS - 6

ER -